Compare RIGL & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIGL | HPK |
|---|---|---|
| Founded | 1996 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 911.8M | 1.0B |
| IPO Year | 2000 | 2020 |
| Metric | RIGL | HPK |
|---|---|---|
| Price | $51.03 | $10.20 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $63.00 | N/A |
| AVG Volume (30 Days) | 187.5K | ★ 636.1K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ 1867.68 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | $294,282,000.00 | ★ $863,359,000.00 |
| Revenue This Year | $3.89 | $12.23 |
| Revenue Next Year | $21.95 | N/A |
| P/E Ratio | $38.83 | ★ N/A |
| Revenue Growth | ★ 64.15 | N/A |
| 52 Week Low | $24.84 | $3.85 |
| 52 Week High | $52.24 | $12.03 |
| Indicator | RIGL | HPK |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 53.39 |
| Support Level | $44.83 | $4.66 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.53 | 0.69 |
| MACD | 0.30 | -0.08 |
| Stochastic Oscillator | 75.79 | 24.90 |
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
HighPeak Energy Inc is an independent crude oil and natural gas exploration and production company that explores for, develops and produces crude oil, NGL, and natural gas prominently in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S. The majority of the company's revenue is derived from the Crude oil sales.